Adaptive Biotechnologies Corporation (ADPT)

Adaptive Biotechnologies Revenue

Adaptive Biotechnologies had revenue of $52.44M in the quarter ending March 31, 2025, with 25.24% growth. This brings the company's revenue in the last twelve months to $189.53M, up 8.61% year-over-year. In the year 2024, Adaptive Biotechnologies had annual revenue of $178.96M with 5.10% growth.

• Revenue (ttm): $189.53M
• Revenue Growth: +8.61%
• P/S Ratio: 7.42
• Revenue / Employee: $306,183
• Employees: 619
• Market Cap: 1.44B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	178.96M	8.68M	5.10%
Dec 31, 2023	170.28M	-15.03M	-8.11%
Dec 31, 2022	185.31M	30.96M	20.06%
Dec 31, 2021	154.34M	55.96M	56.88%
Dec 31, 2020	98.38M	13.31M	15.65%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.